Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & Scope
    • Editorial Board
    • Contact
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Ethics & Integrity
    • Publication Fees
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
The Effects of Vitamin D on Allergen-Induced Expression of Interleukin-13 and Interleukin-17 in Cord Blood CD4+T Cells
Hui Zhong, Xiao Jian Zhou, Jian Gou Hong
Clinical Characteristics and Predictive Factors Analysis of Mycoplasma Pneumoniae Pneumonia Complicated with Pleural Effusion in Children
Lianlian Ji, Liqun Lin, Jian Ye, Zhishu Li
Published: 2025-06-26
Prognostic and Immunotherapeutic Value of Regulatory T Cell Marker Gene Signature in Melanoma
Yurong Liu, Jianlan Liu, Keyu Jiang, Xiaolong Cheng, Sitong Di, Jian Tang, Binlin Luo
Published: 2025-03-10
Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study
Bin Shang, Xiangguo Li, Yu Xu, Wenxin Ren, Junren Wang, Chunyan Xing, Shujuan Jiang, Jian Sun
Published: 2023-06-16
Adenovirus-mediated Gene Therapy for Allergy
Shikun Ma, Jian Guan
Published: 2018-12-01
1 - 5 of 5 items


2024 Impact Factor: 1.2
2024 CiteScore: 2.4


pISSN: 1735-1502
eISSN: 1735-5249


Chairman:
Mostafa Moin, M.D. 

Editors-in-Chief:
Masoud Movahedi, M.D.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

2.4
2024CiteScore
 
 
27th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
Iranian Journal of Allergy, Asthma and Immunology (Bimonthly), pISSN: 1735-1502, eISSN: 1735-5249
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.